Market Challenges and Opportunities in Essential Thrombocythemia Treatment
Introduction
Essential thrombocythemia (ET) is a rare but chronic myeloproliferative disorder characterized by the overproduction of platelets in the bone marrow, leading to an elevated platelet count in the blood. This condition increases the risk of thrombosis (blood clots), bleeding, and other complications. ET is often asymptomatic but can progress to more severe forms of...
0 المشاركات
31 مشاهدة
0 معاينة